Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Pimentel

Showing results (211-220 of 215) with videos related to

Pageof 22
Sort By:
You have reached the last page of results.This site can display upto 215 results.
JAMA|January 19, 2021
Effect of Discontinuing vs Continuing Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers on Days Alive and Out of the Hospital in Patients Admitted With COVID-19: A Randomized Clinical TrialRenato D Lopes, Ariane V S Macedo, Pedro G M de Barros E Silva, et al.
Nature Communications|May 22, 2015
Major histocompatibility complex associations of ankylosing spondylitis are complex and involve further epistasis with ERAP1Adrian Cortes, Sara L Pulit, Paul J Leo, et al.
Acta Reumatologica Portuguesa|March 31, 2018
Portuguese recommendations for the prevention, diagnosis and management of primary osteoporosis - 2018 updateA M Rodrigues, H Canhão, A Marques, et al.
Annals of the Rheumatic Diseases|April 29, 2015
ERAP2 is associated with ankylosing spondylitis in HLA-B27-positive and HLA-B27-negative patientsPhilip C Robinson, Mary-Ellen Costello, Paul Leo, et al.
Nature Genetics|June 11, 2013
Identification of multiple risk variants for ankylosing spondylitis through high-density genotyping of immune-related loci, Adrian Cortes, Johanna Hadler, et al.
Pageof 22

Showing results (211-220 of 215) with videos related to

Sort By:
Pageof 22
You have reached the last page of results.This site can display upto 215 results.
JAMA|January 19, 2021
Effect of Discontinuing vs Continuing Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers on Days Alive and Out of the Hospital in Patients Admitted With COVID-19: A Randomized Clinical TrialRenato D Lopes, Ariane V S Macedo, Pedro G M de Barros E Silva, et al.
Nature Communications|May 22, 2015
Major histocompatibility complex associations of ankylosing spondylitis are complex and involve further epistasis with ERAP1Adrian Cortes, Sara L Pulit, Paul J Leo, et al.
Acta Reumatologica Portuguesa|March 31, 2018
Portuguese recommendations for the prevention, diagnosis and management of primary osteoporosis - 2018 updateA M Rodrigues, H Canhão, A Marques, et al.
Annals of the Rheumatic Diseases|April 29, 2015
ERAP2 is associated with ankylosing spondylitis in HLA-B27-positive and HLA-B27-negative patientsPhilip C Robinson, Mary-Ellen Costello, Paul Leo, et al.
Nature Genetics|June 11, 2013
Identification of multiple risk variants for ankylosing spondylitis through high-density genotyping of immune-related loci, Adrian Cortes, Johanna Hadler, et al.
Pageof 22